Literature DB >> 6410790

Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas.

N J Patronas, R A Brooks, R L DeLaPaz, B H Smith, P L Kornblith, G Di Chiro.   

Abstract

A comparison of the glycolytic rate as determined by positron emission tomography (PET) with 18F-deoxyglucose (FDG) and cerebral contrast computed tomography (CT) was carried out in 72 cases of cerebral glioma. FDG-PET is more accurate than contrast CT in predicting tumor grade.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6410790      PMCID： PMC8335019     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  15 in total

1.  [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors.

Authors:  Seung Jin Choi; Jae Seung Kim; Jeong Hoon Kim; Seung Jun Oh; Jeong Gyo Lee; Chang Jin Kim; Young Shin Ra; Jeong Seok Yeo; Jin Sook Ryu; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-02-15       Impact factor: 9.236

2.  FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future.

Authors:  Abdullah Al-Zaghal; William Y Raynor; Siavash Mehdizadeh Seraj; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01       Impact factor: 9.236

3.  Detection of histological anaplasia in gliomas with oligodendroglial components using positron emission tomography with (18)F-FDG and (11)C-methionine: report of two cases.

Authors:  Shigeru Yamaguchi; Hiroyuki Kobayashi; Kenji Hirata; Tohru Shiga; Shinya Tanaka; Junichi Murata; Shunsuke Terasaka
Journal:  J Neurooncol       Date:  2010-06-15       Impact factor: 4.130

Review 4.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 5.  Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?

Authors:  C S Brock; S R Meikle; P Price
Journal:  Eur J Nucl Med       Date:  1997-06

6.  The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease.

Authors:  N Y Tse; C K Hoh; R A Hawkins; M J Zinner; M Dahlbom; Y Choi; J Maddahi; F C Brunicardi; M E Phelps; J A Glaspy
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

Review 7.  Brain tumors.

Authors:  K L Black; J C Mazziotta; D P Becker
Journal:  West J Med       Date:  1991-02

Review 8.  Tracer imaging in lung cancer.

Authors:  H M Abdel-Dayem; A Scott; H Macapinlac; S Larson
Journal:  Eur J Nucl Med       Date:  1994-01

9.  Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.

Authors:  T Kuwert; C Morgenroth; B Woesler; P Matheja; S Palkovic; B Vollet; S Samnick; U Maasjosthusmann; H Lerch; F J Gildehaus; H Wassmann; O Schober
Journal:  Eur J Nucl Med       Date:  1996-10

10.  Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers.

Authors:  K Sato; M Kameyama; K Ishiwata; R Katakura; T Yoshimoto
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.